Micro Emerging Active

ABUS 目标价因上诉可能性提高而下调

New narrative with limited coverage — still forming.

评分
0.5
动能
▲ 1.0
文章
1
来源
1

Sentiment Timeline

Event Timeline

四月 18, 2026
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal … Neutral

相关文章

Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability

Yahoo Finance · 四月 18, 2026
Mixed

时间线

最后更新四月 18, 2026